JP2022534733A5 - - Google Patents

Info

Publication number
JP2022534733A5
JP2022534733A5 JP2021570530A JP2021570530A JP2022534733A5 JP 2022534733 A5 JP2022534733 A5 JP 2022534733A5 JP 2021570530 A JP2021570530 A JP 2021570530A JP 2021570530 A JP2021570530 A JP 2021570530A JP 2022534733 A5 JP2022534733 A5 JP 2022534733A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
gene construct
microrna
target sequence
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021570530A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022534733A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/065018 external-priority patent/WO2020239995A1/en
Publication of JP2022534733A publication Critical patent/JP2022534733A/ja
Publication of JP2022534733A5 publication Critical patent/JP2022534733A5/ja
Priority to JP2025052575A priority Critical patent/JP2025106333A/ja
Pending legal-status Critical Current

Links

JP2021570530A 2019-05-31 2020-05-29 インスリン遺伝子治療 Pending JP2022534733A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025052575A JP2025106333A (ja) 2019-05-31 2025-03-26 インスリン遺伝子治療

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382447 2019-05-31
EP19382447.1 2019-05-31
PCT/EP2020/065018 WO2020239995A1 (en) 2019-05-31 2020-05-29 Insulin gene therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025052575A Division JP2025106333A (ja) 2019-05-31 2025-03-26 インスリン遺伝子治療

Publications (2)

Publication Number Publication Date
JP2022534733A JP2022534733A (ja) 2022-08-03
JP2022534733A5 true JP2022534733A5 (enExample) 2023-06-26

Family

ID=66752030

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021570530A Pending JP2022534733A (ja) 2019-05-31 2020-05-29 インスリン遺伝子治療
JP2025052575A Pending JP2025106333A (ja) 2019-05-31 2025-03-26 インスリン遺伝子治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025052575A Pending JP2025106333A (ja) 2019-05-31 2025-03-26 インスリン遺伝子治療

Country Status (7)

Country Link
US (1) US20220226501A1 (enExample)
EP (1) EP3976087A1 (enExample)
JP (2) JP2022534733A (enExample)
KR (1) KR20220016100A (enExample)
CN (2) CN113891726A (enExample)
CA (1) CA3140507A1 (enExample)
WO (1) WO2020239995A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118139655A (zh) * 2021-08-13 2024-06-04 特里奥万斯控股公司 皮肤替代组合物及其产生和使用方法
CA3252672A1 (en) * 2022-05-09 2023-11-16 Endsulin, Inc. VARIANT OF PREPROINSULIN AND CONSTRUCTIONS FOR INSULIN EXPRESSION AND THE TREATMENT OF DIABETES

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5436146A (en) 1989-09-07 1995-07-25 The Trustees Of Princeton University Helper-free stocks of recombinant adeno-associated virus vectors
US6268213B1 (en) 1992-06-03 2001-07-31 Richard Jude Samulski Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
US5869305A (en) 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US6204059B1 (en) 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US5741683A (en) 1995-06-07 1998-04-21 The Research Foundation Of State University Of New York In vitro packaging of adeno-associated virus DNA
US6093570A (en) 1995-06-07 2000-07-25 The University Of North Carolina At Chapel Hill Helper virus-free AAV production
US5952221A (en) 1996-03-06 1999-09-14 Avigen, Inc. Adeno-associated virus vectors comprising a first and second nucleic acid sequence
EP1007637B1 (en) 1997-04-14 2004-06-30 Cell Genesys, Inc. Methods for increasing the efficiency of recombinant aav product
US6207455B1 (en) 1997-05-01 2001-03-27 Lung-Ji Chang Lentiviral vectors
CN1247788C (zh) 1997-05-13 2006-03-29 北卡罗来纳-查佩尔山大学 基于慢病毒的基因转移载体
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
US6218181B1 (en) 1998-03-18 2001-04-17 The Salk Institute For Biological Studies Retroviral packaging cell line
US6146874A (en) 1998-05-27 2000-11-14 University Of Florida Method of preparing recombinant adeno-associated virus compositions
EP1135468B1 (en) 1998-11-10 2010-01-06 University Of North Carolina At Chapel Hill Virus vectors and methods of making and administering the same
CA2364417C (en) * 1999-02-19 2013-11-05 Matthew John During Peroral gene therapy of diabetes and obesity
DE19909769A1 (de) 1999-03-05 2000-09-07 Bundesrepublik Deutschland Let Von SIVagm abgeleitete lentivirale Vektoren, Verfahren zu ihrer Herstellung und ihre Verwendung zur Genübertragung in Säugerzellen
AU6814901A (en) 2000-06-01 2001-12-11 Univ North Carolina Methods and compounds for controlled release of recombinant parvovirus vectors
JP2006506044A (ja) * 2002-04-19 2006-02-23 ジョージア テック リサーチ コーポレイション タンパク質分泌ダイナミクスの加速のための組成物及び方法
AU2003274397A1 (en) 2002-06-05 2003-12-22 University Of Florida Production of pseudotyped recombinant aav virions
US20070020237A1 (en) * 2005-06-01 2007-01-25 Biotech Institute For International Innovation, Inc. Glucose inducible insulin expression and methods of treating diabetes
CA2629294A1 (en) * 2005-11-11 2007-05-24 Aurogen Inc. Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin
DK2561073T3 (en) * 2010-04-23 2016-12-12 Univ Massachusetts Aav vectors targeted to central nervous system and methods of use thereof
MY189818A (en) * 2011-12-06 2022-03-10 Halliburton Energy Services Inc Bidirectional downhole fluid flow control system and method
US11085055B2 (en) * 2014-12-05 2021-08-10 Universitat Autonoma De Barcelona Viral vectors for the treatment of diabetes
EP3269823B1 (en) * 2015-03-13 2019-06-05 Hiroshima University Method for assisting detection of alzheimer's disease or mild cognitive impairment
JP7292877B2 (ja) * 2016-01-14 2023-06-19 イントレクソン・アクトバイオテイクス・エヌブイ １型糖尿病を処置するための組成物および方法

Similar Documents

Publication Publication Date Title
JP2020203894A5 (enExample)
MY209860A (en) Gene therapy vectors for treating heart disease
JP2019089787A5 (enExample)
JP2022526018A5 (enExample)
JP2022115876A5 (enExample)
JP2021536244A5 (enExample)
JP2023109992A5 (enExample)
JP2018537984A5 (enExample)
JP2014512171A5 (enExample)
JPWO2019156137A5 (enExample)
JP2023517934A5 (enExample)
RU2012107671A (ru) Композиция для лечения инфекции вирусом гепатита в
JP2022505877A5 (enExample)
JP2018537089A5 (enExample)
JP2022513454A (ja) ＡＩＭＰ２－ＤＸ２およびｍｉＲ－１４２の標的核酸を含むベクター、ならびにその使用
JP2017521074A5 (enExample)
JP2018509154A5 (enExample)
JP2023509118A5 (enExample)
JP2025506173A5 (enExample)
JP2023514659A5 (enExample)
CA3173742A1 (en) Trans-splicing ribozyme specific to apoe4 rna and use thereof
JP2020527167A5 (enExample)
JP2006511212A5 (enExample)
JP2022517988A5 (enExample)
JP2009542609A5 (enExample)